These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17063781)

  • 21. Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding.
    Laleman W; Nevens F
    Minerva Med; 2006 Aug; 97(4):325-45. PubMed ID: 17008837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of propranolol or propranolol plus isosorbide-5-mononitrate on variceal pressure in schistosomiasis.
    Kong DR; Ma C; Wang M; Wang JG; Chen C; Zhang L; Hao JH; Li P; Xu JM
    World J Gastroenterol; 2013 Jul; 19(26):4228-33. PubMed ID: 23864788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doppler sonography and hepatic vein catheterization in portal hypertension: assessment of agreement in evaluating severity and response to treatment.
    Merkel C; Sacerdoti D; Bolognesi M; Bombonato G; Gatta A
    J Hepatol; 1998 Apr; 28(4):622-30. PubMed ID: 9566831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study.
    Kim MY; Baik SK; Park DH; Lim DW; Kim JW; Kim HS; Kwon SO; Kim YJ; Chang SJ; Lee SS
    Liver Int; 2007 Oct; 27(8):1103-10. PubMed ID: 17845539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of effects of propranolol on portal hemodynamics in cirrhosis by duplex ultrasonography.
    Saigal S; Chawla Y; Dilawari JB
    Indian J Gastroenterol; 1998 Apr; 17(2):51-2. PubMed ID: 9563219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis.
    Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Bellini B; Bighin R; Gatta A
    Hepatology; 2000 Nov; 32(5):930-4. PubMed ID: 11050041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
    Vorobioff J; Picabea E; Gamen M; Villavicencio R; Bordato J; Bessone F; Tanno H; Palazzi J; Sarano H; Pozzoli L
    Hepatology; 1993 Sep; 18(3):477-84. PubMed ID: 8359793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.
    Navasa M; Chesta J; Bosch J; Rodés J
    Gastroenterology; 1989 Apr; 96(4):1110-8. PubMed ID: 2925055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "A La Carte" treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding.
    Bureau C; Péron JM; Alric L; Morales J; Sanchez J; Barange K; Payen JL; Vinel JP
    Hepatology; 2002 Dec; 36(6):1361-6. PubMed ID: 12447860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug therapy of pulmonary and portal hypertension in liver cirrhosis].
    Vorob'ev LP; Maev IV; Andreev NG
    Klin Med (Mosk); 1991 Feb; 69(2):64-7. PubMed ID: 1875666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis.
    Bañares R; Moitinho E; Matilla A; García-Pagán JC; Lampreave JL; Piera C; Abraldes JG; De Diego A; Albillos A; Bosch J
    Hepatology; 2002 Dec; 36(6):1367-73. PubMed ID: 12447861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis.
    Angelico M; Carli L; Piat C; Gentile S; Rinaldi V; Bologna E; Capocaccia L
    Gastroenterology; 1993 May; 104(5):1460-5. PubMed ID: 8482456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary prophylaxis with nadolol in cirrhotic patients: Doppler patterns of splanchnic hemodynamics in good and poor responders.
    Berzigotti A; Rinaldi MF; Magalotti D; Morelli MC; Zappoli P; Andreone P; Rossi C; Zoli M
    J Hepatol; 2006 Feb; 44(2):310-6. PubMed ID: 16343679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus reinfection in liver transplant patients: evaluation of liver damage progression with echo-color Doppler.
    Bolognesi M; Quaglio C; Bombonato G; Guido M; Cavalletto L; Chemello L; Merkel C; Rugge M; Gatta A; Sacerdoti D
    Liver Transpl; 2008 May; 14(5):616-24. PubMed ID: 18324620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding.
    Villanueva C; Miñana J; Ortiz J; Gallego A; Soriano G; Torras X; Sáinz S; Boadas J; Cussó X; Guarner C; Balanzó J
    N Engl J Med; 2001 Aug; 345(9):647-55. PubMed ID: 11547718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The acute and chronic effects of isosorbide-5-mononitrate on portal haemodynamics in cirrhosis.
    Grose RD; Plevris JN; Redhead DN; Bouchier IA; Hayes PC
    J Hepatol; 1994 Apr; 20(4):542-7. PubMed ID: 8051395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The randomized controlled trial of isosorbide mononitrate plus propranolol compared with propranolol alone for the prevention of variceal rebleeding].
    Zhang Q; Yuan R; Wang H
    Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(17):1157-9. PubMed ID: 12475399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Portal hemodynamics in cirrhotics with portal hypertension using color Doppler velocity profile.
    Huang J; Yin X; Lu M; Chen J; Liang L
    Chin Med J (Engl); 1999 Jul; 112(7):627-31. PubMed ID: 11601258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of action of isosorbide-5-mononitrate in reducing portal pressure in cirrhotic patients with cirrhosis and portal hypertension.
    Jenkins SA; Shields R
    J Gastroenterol Hepatol; 1991; 6(1):91-3. PubMed ID: 1883984
    [No Abstract]   [Full Text] [Related]  

  • 40. Long term effects of propranolol on portal pressure in cirrhotic patients.
    Orban-Schiopu AM; Popescu CR
    Rom J Gastroenterol; 2003 Mar; 12(1):25-30. PubMed ID: 12673376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.